We are live on ! Find out more

SGYP

Synergy Pharmaceuticals, Inc Common Stock

SGYP

Delisted

SGYP was delisted on the 7th of March, 2019.

134 hedge funds and large institutions have $164M invested in Synergy Pharmaceuticals, Inc Common Stock in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New

Increased

Maintained

Reduced

Closed

4% less capital invested

Capital invested by funds: $170M → $164M (-$6.35M)

2% less funds holding

Funds holding: 137 → 134 (-3)

14% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 36

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

43% less call options, than puts

Call options by funds: $2.63M | Put options by funds: $4.61M

Holders

134

Holders Change

-3

Holders Change %

-2.19%

% of All Funds

3.06%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$2.63M

Puts

$4.61M

Net Calls

-$1.99M

Net Calls Change

+$157K

Top Buyers

Rank	Fund	Capital Flow
1	Vanguard Group Malvern, Pennsylvania	+$2.19M
2	HighTower Advisors Chicago, Illinois	+$1.73M
3	NC Nexthera Capital New York	+$1.34M
4	BlackRock New York	+$1.02M
5	CEP Chicago Equity Partners Chicago, Illinois	+$512K

Top Sellers

Rank	Fund	Capital Flow
1	NCM Nantahala Capital Management New Canaan, Connecticut	-$5.93M
2	State Street Boston, Massachusetts	-$2.23M
3	Balyasny Asset Management Chicago, Illinois	-$1.2M
4	Susquehanna International Group Bala Cynwyd, Pennsylvania	-$455K
5	DMK David M. Knott	-$392K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
101	PAG 101 Private Advisor Group Morristown, New Jersey	$26K	+$27.8K	+15,535	New
102	102 Zurich Cantonal Bank Zurich, Switzerland	$25K	–	–	–
103	AB 103 Amalgamated Bank New York	$24K	-$42.2K	-23,598	-62%
104	104 BNP Paribas Financial Markets Paris, France	$23.4K	-$3.03K	-1,691	-11%
105	105 Stifel Financial St. Louis, Missouri	$23K	–	–	–
106	106 Millennium Management New York	$21K	-$181K	-101,071	-89%
107	107 MML Investors Services Springfield, Massachusetts	$19K	–	–	–
108	APA 108 American Portfolios Advisors Holbrook, New York	$18K	+$4.56K	+2,550	+32%
109	S 109 SignatureFD Atlanta, Georgia	$17K	–	–	–
110	ACP 110 Aveo Capital Partners Englewood, Colorado	$14K	–	–	–
111	OGC 111 Oak Grove Capital North Hampton, New Hampshire	$13K	–	–	–
112	BA 112 Ballew Advisors Jackson, Mississippi	$11K	–	–	–
113	IA 113 IFP Advisors Tampa, Florida	$11K	–	–	–
114	114 Credit Agricole Montrouge Cedex, France	$10K	-$8.05K	-4,497	-43%
115	BWA 115 BDO Wealth Advisors Jacksonville, Florida	$7K	–	–	–
116	VNA 116 Valley National Advisers Bethlehem, Pennsylvania	$7K	–	–	–
117	SWP 117 Stratos Wealth Partners Beachwood, Ohio	$7K	+$7.16K	+4,000	New
118	LTFS 118 Ladenburg Thalmann Financial Services Miami, Florida	$5K	-$2.99K	-1,672	-36%
119	FDCDDQ 119 Federation des caisses Desjardins du Quebec Levis, Quebec, Canada	$4.12K	–	–	–
120	QAM 120 QCI Asset Management Pittsford, New York	$4K	–	–	–
121	121 Nisa Investment Advisors St. Louis, Missouri	$3K	-$6.32K	-3,530	-64%
122	KJWM 122 Kiley Juergens Wealth Management Olympia, Washington	$3K	–	–	–
123	KF 123 Krilogy Financial St. Louis, Missouri	$3K	+$2.69K	+1,500	New
124	124 Daiwa Securities Group Tokyo, Japan	$2K	–	–	–
125	FIA 125 FNY Investment Advisers New York	$2K	+$895	+500	+50%

SGYP Hedge Fund Activity: Q3 2018 in Review

134 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q3 2018, worth a combined $164M — down 3.7% from $170M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of SGYP and 17 opened new positions — a net loss of 3 holders — while 36 trimmed existing stakes and 31 added.

The largest buyer was Vanguard Group, adding an estimated $2.19M. The largest seller was Nantahala Capital Management, cutting an estimated $5.93M.

134 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q3 2018, down from 137 in Q2 2018.
Funds reported $164M of Synergy Pharmaceuticals, Inc Common Stock stock for Q3 2018, down 3.7% quarter-over-quarter.
17 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q3 2018 and 20 closed out, a net change of -3 holders.
The largest Synergy Pharmaceuticals, Inc Common Stock buyer in Q3 2018 was Vanguard Group, an estimated $2.19M added.
The largest Synergy Pharmaceuticals, Inc Common Stock seller in Q3 2018 was Nantahala Capital Management, an estimated $5.93M sold.

Based on aggregated 13F filings for Q3 2018.

Synergy Pharmaceuticals, Inc Common Stock SGYP